#biontech

[ follow ]
NYC startup
fromMedCity News
1 month ago

BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute - MedCity News

BioNTech acquires CureVac to strengthen mRNA capabilities and mitigate legal risks amidst ongoing patent disputes.
fromwww.independent.co.uk
2 months ago

Vaccine maker's 1bn UK investment to create hundreds of high-skilled jobs'

"Biopharmaceutical company BioNTech has announced funding of up to 1 billion into the UK over the next 10 years, marking one of the largest investments in UK life sciences."
London startup
[ Load more ]